VENUSREM

VENUS REMEDIES

Small Cap BSE: 526953 NSE: VENUSREM
₹200.55
1.3 (0.65%)
As on 01 December, 2022 | 06:34

Venus Remedies Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in VENUS REMEDIES

Start SIP

Venus Remedies Share Price

Venus Remedies Share Returns

  • Over 1 Month -6.85%
  • Over 3 Month -8.42%
  • Over 6 Month -1.21%
  • Over 1 Year -54.88%

Venus Remedies Key Statistics

P/E Ratio 14.8
PEG Ratio -0.2
Market Cap Cr 268
Price to Book Ratio 0.6
EPS 36.6
Dividend 0
Relative Strength Index 48.9
Money Flow Index 49.49
MACD Signal -2.99
Average True Range 7.03

Venus Remedies Investment Rating

  • Master Rating:
  • Venus Remedies has an operating revenue of Rs. 549.25 Cr. on a trailing 12-month basis. An annual revenue growth of 7% is good, Pre-tax margin of 6% is okay, ROE of 9% is fair but needs improvement. The company has a reasonable debt to equity of 9%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 14 which is a POOR score indicating inconsistency in earnings, a RS Rating of 7 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 124 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Venus Remedies Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 125155128117193137102
Operating Expenses Qtr Cr 11013712110316511795
Operating Profit Qtr Cr 151871428198
Depreciation Qtr Cr 9878889
Interest Qtr Cr 0000001
Tax Qtr Cr 010-1-2-2-17
Net Profit Qtr Cr 81128241539

Venus Remedies Technicals

EMA & SMA

Current Price
200.55
1.3 (0.65%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 200.15
  • 50 Day
  • 204.86
  • 100 Day
  • 215.33
  • 200 Day
  • 238.68
  • 20 Day
  • 200.58
  • 50 Day
  • 205.52
  • 100 Day
  • 211.17
  • 200 Day
  • 238.46

Venus Remedies Resistance and Support

PIVOT
₹199.6
Resistance
First Resistance 201.65
Second Resistance 204.05
Third Resistance 206.1
RSI 48.9
MFI 49.49
MACD Single Line -2.99
MACD -2.5
Support
First Resistance 197.2
Second Resistance 195.15
Third Resistance 192.75

Venus Remedies Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 15,609 931,233 59.66
Week 30,330 1,612,322 53.16
1 Month 35,179 2,136,415 60.73
6 Month 61,526 3,036,303 49.35

Venus Remedies Result Highlights

Venus Remedies Synopsis

NSE-Medical-Diversified

Venus Remedies L is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 575.18 Cr. and Equity Capital is Rs. 13.37 Cr. for the Year ended 31/03/2022. Venus Remedies Ltd. is a Public Limited Listed company incorporated on 15/09/1989 and has its registered office in the State of Chandigarh, India. Company’s Corporate Identification Number(CIN) is L24232CH1989PLC009705 and registration number is 009705.
Market Cap 268
Sales 525
Shares in Float 0.78
No of funds 8
Yield
Book Value 0.6
U/D Vol ratio 0.7
LTDebt / Equity 9
Alpha -0.3
Beta 1.15

Venus Remedies

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 41.76%41.76%40.81%
Mutual Funds
Foreign Portfolio Investors 1.13%0.96%0.33%
Individual Investors 50.18%49.97%51.72%
Others 6.93%7.31%7.14%

Venus Remedies Management

Name Designation
Mr. Pawan Chaudhary Chairman & Managing Director
Dr.(Mrs.) Manu Chaudhary Joint Managing Director
Mr. Peeyush Jain Deputy Managing Director
Mr. Ashutosh Jain Executive Director
Mr. Navdeep Sud Independent Director
Dr. Gilbert Wenzel Non Executive Director
Dr. S K Chadha Independent Director
Mr. Pravindra Singh Chauhan Independent Director
Dr.(Mrs.) Savita Gupta Independent Director
Mr. Akshansh Chaudhary Executive Director

Venus Remedies Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Venus Remedies Corporate Action

Date Purpose Remarks
2022-11-12 Quarterly Results
2022-07-30 Quarterly Results
2022-05-27 Audited Results
2022-01-31 Quarterly Results
2021-12-30 Others Inter alia, to consider the appointment of additional director Independent director.

Venus Remedies MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Venus Remedies FAQs

What is Share Price of Venus Remedies ?

Venus Remedies share price is ₹200 As on 01 December, 2022 | 06:20

What is the Market Cap of Venus Remedies ?

The Market Cap of Venus Remedies is ₹268.1 Cr As on 01 December, 2022 | 06:20

What is the P/E ratio of Venus Remedies ?

The P/E ratio of Venus Remedies is 14.8 As on 01 December, 2022 | 06:20

What is the PB ratio of Venus Remedies ?

The PB ratio of Venus Remedies is 0.6 As on 01 December, 2022 | 06:20

Q2FY23